FDA puts hold on ACT trial

Sunday 10 January 2010

The US Food and Drug Administration has put a ‘clinical hold’ on a proposed first-in-man study of a new embryonic stem cell treatment for eye disease, according to the developer.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United States

See map: Google Maps